Michael Noel Neely (Michael Neely, Michael N Neely)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 33

Top Topics

Acinetobacter Baumannii

Top Venues

CPT: pharmacometrics & systems pharmacology

Microbiology spectrum

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Gellert Balazs Karvaly, István Vincze, Michael Noel Neely, István Zátroch, Zsuzsanna Nagy, Ibolya Kocsis, Csaba Kopitkó
Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin. Pharmaceutics 16 (3) (2024)
Gellert Balazs Karvaly, István Vincze, Michael Noel Neely, István Zátroch, Zsuzsanna Nagy, Ibolya Kocsis, Csaba Kopitkó
Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin. Pharmaceutics 16 (3) (2024)
Joy E Gibson, Nishant Nandanwar, Michael Noel Neely
Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence. Microbiology spectrum 12 (2) (2024)
Sean N Avedissian, Johid Reza Malik, Anthony T Podany, Michael Noel Neely, Nathaniel James Rhodes, Kimberly K Scarsi, Marc H Scheetz, Michael J Duryee, Ukamaka O Modebelu, Timothy M Mykris, Lee C Winchester, Siddappa N Byrareddy, Courtney V Fletcher
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells. Scientific reports 14 (1) (2024)
Sean N Avedissian, Johid Reza Malik, Anthony T Podany, Michael Noel Neely, Nathaniel James Rhodes, Kimberly K Scarsi, Marc H Scheetz, Michael J Duryee, Ukamaka O Modebelu, Timothy M Mykris, Lee C Winchester, Siddappa N Byrareddy, Courtney V Fletcher
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells. Scientific reports 14 (1) (2024)
Sumith K Mathew, Aaron Chapla, Padmanaban Venkatesan, Vishnu Eriyat, Blessed Winston Aruldhas, Ratna Prabha, Michael Noel Neely, Shoma V Rao, Subramani Kandasamy, Binu Susan Mathew
Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity. Clinical and translational science 17 (3) (2024)
Rong Chen, Alan Schumitzky, Alona Kryshchenko, Keith Nieforth, Michael Tomashevskiy, Shuhua Hu, Romain Garreau, Julian D Otalvaro, Walter M Yamada, Michael Noel Neely
RPEM: Randomized Monte Carlo parametric expectation maximization algorithm. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Sumith K Mathew, Aaron Chapla, Padmanaban Venkatesan, Vishnu Eriyat, Blessed Winston Aruldhas, Ratna Prabha, Michael Noel Neely, Shoma V Rao, Subramani Kandasamy, Binu Susan Mathew
Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity. Clinical and translational science 17 (3) (2024)
Rong Chen, Alan Schumitzky, Alona Kryshchenko, Keith Nieforth, Michael Tomashevskiy, Shuhua Hu, Romain Garreau, Julian D Otalvaro, Walter M Yamada, Michael Noel Neely
RPEM: Randomized Monte Carlo parametric expectation maximization algorithm. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Gellert Balazs Karvaly, István Vincze, Michael Noel Neely, István Zátroch, Zsuzsanna Nagy, Ibolya Kocsis, Csaba Kopitkó
Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin. Pharmaceutics 16 (3) (2024)
Rong Chen, Alan Schumitzky, Alona Kryshchenko, Keith Nieforth, Michael Tomashevskiy, Shuhua Hu, Romain Garreau, Julian D Otalvaro, Walter M Yamada, Michael Noel Neely
RPEM: Randomized Monte Carlo parametric expectation maximization algorithm. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Sumith K Mathew, Aaron Chapla, Padmanaban Venkatesan, Vishnu Eriyat, Blessed Winston Aruldhas, Ratna Prabha, Michael Noel Neely, Shoma V Rao, Subramani Kandasamy, Binu Susan Mathew
Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin-induced nephrotoxicity. Clinical and translational science 17 (3) (2024)
Sean N Avedissian, Johid Reza Malik, Anthony T Podany, Michael Noel Neely, Nathaniel James Rhodes, Kimberly K Scarsi, Marc H Scheetz, Michael J Duryee, Ukamaka O Modebelu, Timothy M Mykris, Lee C Winchester, Siddappa N Byrareddy, Courtney V Fletcher
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells. Scientific reports 14 (1) (2024)
Joy E Gibson, Nishant Nandanwar, Michael Noel Neely
Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence. Microbiology spectrum 12 (2) (2024)
Sean N Avedissian, Johid Reza Malik, Anthony T Podany, Michael Noel Neely, Nathaniel James Rhodes, Kimberly K Scarsi, Marc H Scheetz, Michael J Duryee, Ukamaka O Modebelu, Timothy M Mykris, Lee C Winchester, Siddappa N Byrareddy, Courtney V Fletcher
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells. Scientific reports 14 (1) (2024)
Rong Chen, Alan Schumitzky, Alona Kryshchenko, Keith Nieforth, Michael Tomashevskiy, Shuhua Hu, Romain Garreau, Julian D Otalvaro, Walter M Yamada, Michael Noel Neely
RPEM: Randomized Monte Carlo parametric expectation maximization algorithm. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Joy E Gibson, Nishant Nandanwar, Michael Noel Neely
Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence. Microbiology spectrum 12 (2) (2024)
Joy E Gibson, Nishant Nandanwar, Michael Noel Neely
Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence. Microbiology spectrum (2024)
Rong Chen, Alan Schumitzky, Alona Kryshchenko, Keith Nieforth, Michael Tomashevskiy, Shuhua Hu, Romain Garreau, Julian D Otalvaro, Walter M Yamada, Michael Noel Neely
RPEM: Randomized Monte Carlo parametric expectation maximization algorithm. CPT: pharmacometrics & systems pharmacology (2024)
Kevin James Downes, Athena F Zuppa, Anna Sharova, Michael Noel Neely
Optimizing Vancomycin Therapy in Critically Ill Children: A Population Pharmacokinetics Study to Inform Vancomycin Area under the Curve Estimation Using Novel Biomarkers. Pharmaceutics 15 (5) (2023)
Thomas J Sferra, Tomas Merta, Michael Noel Neely, Claudia Murta de Oliveira, Alvaro Lassaletta, Claudia Fortuny Guasch, Mary Beth Dorr, Gregory Winchell, Feng-Hsiu Su, Sarah Perko, Doreen Fernsler, Hetty Waskin, Stephen R Holden
Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III). Journal of the Pediatric Infectious Diseases Society 12 (6) (2023)
Etan Orgel, Kristin R Knight, Yueh-Yun Chi, Jemily Malvar, Teresa Rushing, Victoria Mena, Laurie S Eisenberg, Shahrad Rod Rassekh, Colin J D Ross, Erika N Scott, Michael Noel Neely, Edward A Neuwelt, Leslie L Muldoon, David R Freyer
INTRAVENOUS N-ACETYLCYSTEINE TO PREVENT CISPLATIN-INDUCED HEARING LOSS IN CHILDREN: A NONRANDOMIZED CONTROLLED PHASE 1 TRIAL. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Roxane Rohani, Paul R Yarnold, Marc H Scheetz, Michael Noel Neely, Mengjia Kang, Helen K Donnelly, Kay Dedicatoria, Sophie H Nozick, Rachel L Medernach, Alan R Hauser, Egon Anderson Ozer, Estefani Diaz, Alexander V Misharin, Richard G Wunderink, Nathaniel James Rhodes
Individual meropenem epithelial lining fluid and plasma PK/PD target attainment. Antimicrobial agents and chemotherapy (2023)
Hirsh Elhence, Kanokporn Mongkolrattanothai, Sindhu Mohandas, Michael Noel Neely
Isavuconazole Pharmacokinetics and Pharmacodynamics in Children. Pharmaceutics 15 (1) (2022)
Hirsh Elhence, Kanokporn Mongkolrattanothai, Sindhu Mohandas, Michael Noel Neely
Isavuconazole Pharmacokinetics and Pharmacodynamics in Children. Pharmaceutics 15 (1) (2022)
Hirsh Elhence, Kanokporn Mongkolrattanothai, Sindhu Mohandas, Michael Noel Neely
Isavuconazole Pharmacokinetics and Pharmacodynamics in Children. Pharmaceutics 15 (1) (2022)
Walter M Yamada, Sarah Kim, Mohammed Almoslem, Soyoung Kim, Jenny Myrick, Jocelyn Nole, Brandon Duncanson, Arnold Louie, Charles A Peloquin, Stephan Schmidt, George L Drusano, Michael Noel Neely
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype. Antimicrobial agents and chemotherapy 66 (10) (2022)
Hirsh Elhence, Kanokporn Mongkolrattanothai, Sindhu Mohandas, Michael Noel Neely
Isavuconazole Pharmacokinetics and Pharmacodynamics in Children. Pharmaceutics 15 (1) (2022)
Silke Gastine, Georg Hempel, Michael Noel Neely, Thomas J Walsh, Andreas H Groll
Pharmacokinetic modelling of caspofungin to develop an extended dosing regimen in paediatric patients. The Journal of antimicrobial chemotherapy 77 (8) (2022)
Hirsh Elhence, Kanokporn Mongkolrattanothai, Sindhu Mohandas, Michael Noel Neely
Isavuconazole Pharmacokinetics and Pharmacodynamics in Children. Pharmaceutics 15 (1) (2022)
Jiajun Liu, Michael Noel Neely, Jeffrey Lipman, Fekade Bruck Sime, Jason Alexander Roberts, Patrick J Kiel, Sean N Avedissian, Nathaniel James Rhodes, Marc H Scheetz
Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime. Clinical pharmacokinetics 59 (8) (2021)
Sarah Kim, Walter M Yamada, Brandon Duncanson, Jocelyn Nole, Stephanie Rogers, Sarah Parker, Meredith Bacci, Nino Mtchedlidze, Charles A Peloquin, Arnold Louie, Stephan Schmidt, George L Drusano, Michael Noel Neely
Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase. Antimicrobial agents and chemotherapy 65 (10) (2021)
David S Bayard, Michael Noel Neely
Experiment design for nonparametric models based on minimizing Bayes Risk: application to voriconazole¹. Journal of pharmacokinetics and pharmacodynamics 44 (2) (2016)